Amgen (AMGN): FY26 Q2 earnings call, Aug 4, 2026
No Kalshi or Polymarket word markets were listed for Amgen’s Aug 4, 2026 earnings call (FY26 Q2). The transcript is searchable below (quotes of at most 25 words).
UpdatedTranscript
quotes of at most 25 wordsSpeaker-labelled transcript · Source and credits · Used to count words; quotes of at most 25 words.
1 match for “Eosinophilic”; 1 quoted, at least 25 words apart.
…where epithelial-driven inflammation plays a key role. Our phase III study in eosinophilic esophagitis, or EoE, is expected to complete in the second half of…
Agents: this page as TSV at /api/v1/appearances/amgen:2026-08-04:earnings_call · words: /api/v1/brief?appearance=amgen:2026-08-04:earnings_call · columnar JSON in #parrot-data · llms.txt · MCP